Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!
Chongqing Pharscin Pharmaceutical Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 6/6
Chongqing Pharscin Pharmaceutical has a total shareholder equity of CN¥1.7B and total debt of CN¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CN¥1.9B and CN¥231.8M respectively. Chongqing Pharscin Pharmaceutical's EBIT is CN¥33.3M making its interest coverage ratio -3.2. It has cash and short-term investments of CN¥442.7M.
Anahtar bilgiler
0%
Borç/özkaynak oranı
CN¥0
Borç
| Faiz karşılama oranı | -3.2x |
| Nakit | CN¥442.75m |
| Eşitlik | CN¥1.66b |
| Toplam yükümlülükler | CN¥231.82m |
| Toplam varlıklar | CN¥1.89b |
Son finansal sağlık güncellemeleri
Güncelleme yok
Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: 002907's short term assets (CN¥952.9M) exceed its short term liabilities (CN¥188.8M).
Uzun Vadeli Yükümlülükler: 002907's short term assets (CN¥952.9M) exceed its long term liabilities (CN¥43.0M).
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: 002907 is debt free.
Borcun Azaltılması: 002907 has no debt compared to 5 years ago when its debt to equity ratio was 4.8%.
Borç Kapsamı: 002907 has no debt, therefore it does not need to be covered by operating cash flow.
Faiz Kapsamı: 002907 has no debt, therefore coverage of interest payments is not a concern.